Microbial translocation and T cell activation are modified by direct-acting antiviral therapy in HCV-infected patients
BACKGROUND:
Microbial translocation from the gut lumen has been involved in the pathogenesis of liver damage in hepatitis C virus (HCV) infection.
AIM:
To investigate the impact of direct-acting antiviral treatment on microbial translocation and T-cell activation, in patients with hepatitis C-related liver disease.
METHODS: